183 related articles for article (PubMed ID: 15013872)
1. Photodynamic therapy for age-related macular degeneration: a candid appraisal.
Sternberg P; Lewis H
Am J Ophthalmol; 2004 Mar; 137(3):483-5. PubMed ID: 15013872
[No Abstract] [Full Text] [Related]
2. Photodynamic therapy for age-related macular degeneration.
Beck RW
Am J Ophthalmol; 2004 Sep; 138(3):513; author reply 513-4. PubMed ID: 15364257
[No Abstract] [Full Text] [Related]
3. Photodynamic therapy with verteporfin is effective for selected patients with neovascular age-related macular degeneration.
Fine SL
Arch Ophthalmol; 1999 Oct; 117(10):1400-2. PubMed ID: 10532450
[No Abstract] [Full Text] [Related]
4. Influence of lesion size on treatment benefit with photodynamic therapy.
Essex RW
Clin Exp Ophthalmol; 2004 Aug; 32(4):452-3. PubMed ID: 15281993
[No Abstract] [Full Text] [Related]
5. Treatment of juxtafoveal choroidal neovascularization with photodynamic therapy using verteporfin in eyes with age-related macular degeneration.
Hariprasad SM; Shah GK
Ophthalmic Surg Lasers Imaging; 2005; 36(3):258-60. PubMed ID: 15957487
[TBL] [Abstract][Full Text] [Related]
6. Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization-verteporfin in photodynamic therapy report 2.
Bressler NM
Am J Ophthalmol; 2002 Jan; 133(1):168-9. PubMed ID: 11755871
[No Abstract] [Full Text] [Related]
7. Are the submacular surgery trials still relevant in an era of photodynamic therapy?
Bressler NM; Hawkins BS; Sternberg P; McDonald HR
Ophthalmology; 2001 Mar; 108(3):435-6. PubMed ID: 11237895
[No Abstract] [Full Text] [Related]
8. Treatment of choroidal neovascularization in AMD.
Weinberg DV; Jampol LM
Ophthalmology; 2006 Dec; 113(12):2372; author reply 2372-3. PubMed ID: 17157142
[No Abstract] [Full Text] [Related]
9. Comment on 'Photodynamic therapy in practice'.
Styles C
Clin Exp Ophthalmol; 2004 Feb; 32(1):119-20. PubMed ID: 14746611
[No Abstract] [Full Text] [Related]
10. Verteporfin therapy for subfoveal choroidal neovascularization in age-related macular degeneration: four-year results of an open-label extension of 2 randomized clinical trials: TAP Report No. 7.
Bressler NM; Bressler SB; Haynes LA; Hao Y; Kaiser PK; Miller JW; Naor J; Potter MJ; Pournaras CJ; Reaves A; Rosenfeld PJ; Schmidt-Erfurth U; Slakter JS; Strong A; Vannier S
Arch Ophthalmol; 2005 Sep; 123(9):1283-5. PubMed ID: 16157822
[No Abstract] [Full Text] [Related]
11. [Results of photodynamic treatment of choroidal neovascular membrane in age-related macular degeneration].
Dubská Z; Kalvodová B
Cas Lek Cesk; 2006; 145(10):800, 802-3. PubMed ID: 17121073
[No Abstract] [Full Text] [Related]
12. The role of photodynamic therapy in ophthalmology.
Sivaprasad S; Hykin P
Br J Hosp Med (Lond); 2006 Dec; 67(12):647-50. PubMed ID: 17328448
[No Abstract] [Full Text] [Related]
13. Treatment of juxtafoveal and extrafoveal choroidal neovascularization in the era of photodynamic therapy with verteporfin.
Jampol LM; Scott L
Am J Ophthalmol; 2002 Jul; 134(1):99-101. PubMed ID: 12095815
[No Abstract] [Full Text] [Related]
14. Photodynamic therapy with verteporfin combined with intravitreal injection of bevacizumab for exudative age-related macular degeneration.
Aggio FB; Melo GB; Höfling-Lima AL; Eid Farah M
Acta Ophthalmol Scand; 2006 Dec; 84(6):831-3. PubMed ID: 17083553
[No Abstract] [Full Text] [Related]
15. Photodynamic therapy in adult-onset vitelliform macular dystrophy misdiagnosed as choroidal neovascularization.
Menchini U; Giacomelli G; Cappelli S; Giansanti F; Romani A; Virgili G
Arch Ophthalmol; 2002 Dec; 120(12):1761-3. PubMed ID: 12470159
[No Abstract] [Full Text] [Related]
16. Photodynamic therapy with verteporfin (Visudyne): impact on ophthalmology and visual sciences.
Bressler NM; Bressler SB
Invest Ophthalmol Vis Sci; 2000 Mar; 41(3):624-8. PubMed ID: 10711673
[No Abstract] [Full Text] [Related]
17. The efficacy of photodynamic therapy combined with intravitreal triamcinolone acetonide (TA) for treatment of occult choroidal neovascularization secondary to age-related macular degeneration.
Ho TC
Retina; 2006; 26(6):714; author reply 715. PubMed ID: 16829825
[No Abstract] [Full Text] [Related]
18. Verteporfin therapy for subfoveal choroidal neovascularization in age-related macular degeneration: from clinical trials to clinical practice.
Sickenberg M
Semin Ophthalmol; 2001 Dec; 16(4):207-12. PubMed ID: 15513442
[TBL] [Abstract][Full Text] [Related]
19. Verteporfin photodynamic therapy in the UK: implications of the NICE appraisal.
Harding S
Eye (Lond); 2003 Mar; 17(2):119-22. PubMed ID: 12640394
[No Abstract] [Full Text] [Related]
20. Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration.
Jonas JB
Am J Ophthalmol; 2002 Jun; 133(6):857; author reply 857-9. PubMed ID: 12036694
[No Abstract] [Full Text] [Related]
[Next] [New Search]
